Ryan Preblick
Director of Finance/CFO at INDIVIOR PLC
Net worth: 1 M $ as of 2024-03-30
Ryan Preblick active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INDIVIOR PLC | Director of Finance/CFO | 2020-06-28 | - |
| Director/Board Member | 2020-11-19 | - | |
| Comptroller/Controller/Auditor | 2011-12-31 | 2019-12-31 | |
| Corporate Officer/Principal | 2019-12-31 | 2020-06-28 | |
| OPIANT PHARMACEUTICALS, INC. | Director of Finance/CFO | - | - |
| Corporate Secretary | - | - | |
| Treasurer | - | - |
Career history of Ryan Preblick
Training of Ryan Preblick
| The Pennsylvania State University | Undergraduate Degree |
| University of Richmond | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| INDIVIOR PLC | Health Technology |
| Private companies | 1 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Stock Market
- Insiders
- Ryan Preblick
- Experience